89bio (NASDAQ:ETNB) Stock Quotes, Forecast and News Summary

Q: What sector and industry does 89bio (ETNB) operate in?

89bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

89bio Stock (NASDAQ: ETNB) stock price, news, charts, stock research, profile.

Open	$7.60
Close	-
Volume / Avg.	207.93K / 731.34K
Day Range	$7.44 - $7.76
52 Wk Range	6.58 - 16.63
Market Cap	$743.78M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	9.28%
Days to Cover	15.68

Recent News

What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?

Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment. Further trials needed to confirm efficacy and safety.

Vandana Singh

Over $20M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.

Avi Kapoor

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.60
Close	-
Volume / Avg.	207.93K / 731.34K
Day Range	$7.44 - $7.76
52 Wk Range	6.58 - 16.63
Market Cap	$743.78M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	9.28%
Days to Cover	15.68

About 89bio Inc

Sector

Health Care

Industry

Biotechnology

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the developme...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy 89bio (ETNB) stock?

You can purchase shares of 89bio (NASDAQ:ETNB) through any online brokerage.

View our list of the best stock brokerages

Who are 89bio (ETNB) competitors?

Other companies in 89bio’s space includes: Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), Replimune Group (NASDAQ:REPL), Tango Therapeutics (NASDAQ:TNGX) and Mesoblast (NASDAQ:MESO).

What is the forecast, or price target, for 89bio (ETNB) stock?

89bio has a consensus price target of $29.60.

What is the current price for 89bio (ETNB)?

The stock price for 89bio (NASDAQ: ETNB) is $7.56 last updated September 25, 2024 at 12:30 PM EDT.

Does 89bio (ETNB) pay a dividend?

There are no upcoming dividends for 89bio.

When is 89bio (NASDAQ:ETNB) reporting earnings?

89bio’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is 89bio (ETNB) going to split?

There is no upcoming split for 89bio.

What sector and industry does 89bio (ETNB) operate in?

89bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge